MediPharm Labs has signed a share purchase agreement with Kensana Health for the purchase and sale of its facility in Napanee, Ontario. This comes through a disposition of all of the company’s indirect equity interests in its wholly-owned subsidiary ABcann Medicinals to Kensana for $5.5 million in cash.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Redecan Cannabis launches new limited-edition genetics and expands ‘Wrapped & Redee’ pre-roll line for the holidays
2 | Fluent brings the heat to the “Big Apple” with debut of cannabis brand Knack
3 | Cansortium acquires RIV Capital, accelerates entry into one of the world’s largest and fastest growing cannabis markets
Top Cannabis Stocks Dec. 13 to Dec. 19, 2024
1. T.TLRY | 7,321 views | Tilray Brands Inc.
2. T.WEED | 4,885 views | Canopy Growth Corp.
3. C.CURA | 4,536 views | Curaleaf Holdings Inc.
4. T.LABS | 4,585 views | Medipharm Labs Corp.
5. T.OGI | 1,581 views | Organigram Holdings Inc.
6. C.OILS | 654 views | Nextleaf Solutions Inc.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
